Section Head, Inflammatory Bowel Disease

Associate Professor Emily Wright is a gastroenterologist consulting at St Vincent’s Hospital Melbourne. She is committed to providing wholistic medical care with compassion to help improve the quality of life for people with inflammatory bowel disease and irritable bowel syndrome. A/Prof. Wright has a special interest in inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).

A/Prof. Wright graduated from Monash University and completed her internal medicine and specialist gastroenterology training at St Vincent’s Hospital in Melbourne. She was awarded a National Health and Medical Research Council post-graduate scholarship for the completion of a fellowship in inflammatory bowel disease. To further her expertise and skills, she underwent additional training in Calgary, Canada in IBD. She attained a PhD from the University of Melbourne, examining the clinical and microbiological features of Crohn’s disease.

A/Prof. Wright is heavily involved in research into IBD and IBS. Her research into the monitoring and management of Crohn’s disease and the gut microbiome has been widely published and presented at a number of national and international gastroenterology conferences.

Recent Articles

Adalimumab Clearance, rather than Trough Level, May Have Greatest Relevance to Crohn’s Disease Therapeutic Outcomes Assessed Clinically and Endoscopically. Wright EK, Chaparro M, Gionchetti P, Hamilton AL, Schulberg J, Gisbert JP, Valerii MC, Rizzello F, De Cruz P, Panetta JC, Everts-van der Wind A, Kamm MA, Dervieux T. J Crohns Colitis. 2023 Aug 18:jjad140.

Evaluation and management of ileal pouch-anal anastamosis (IPAA) complications in pregnancy, and the impacts of an IPAA on fertility. Prentice RE, Wright EK, Flanagan E, Kamm MA, Goldberg R, Ross AL, Burns M, Bell SJ. Eur J Gastroenterol Hepatol. 2023 May 1;35(5):609-612.

Relationship Between Serum Ustekinumab Trough Concentration and Clinical and Biochemical Disease Activity: A Real-World Study in Adult Patients with Crohn’s Disease.Nguyen KM, Mattoo VY, Vogrin S, Basnayake C, Connell WR, Ding NS, Flanagan E, Kamm MA, Lust M, Niewiadomski O, Schulberg JD, Wright EK. Eur J Drug Metab Pharmacokinet. 2023 May;48(3):271-279.